選択的アゴニストの世界市場予測 2024年：企業別、地域別、種類・用途別（～2024）

• 英文タイトル：Global Selective Agonists Market 2019 by Company, Regions, Type and Application, Forecast to 2024

• レポートコード：B-GIR08C5100
• 出版社/出版日：GlobalInfoResearch / 2019年7月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、136ページ
• 納品方法：Eメール
• 産業分類：Pharma & Healthcare

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

本調査レポートは、選択的アゴニストの世界市場について調べ、まとめました。種類別セグメントは、α1選択的アゴニスト、α2選択的アゴニスト、β1選択的アゴニスト、β2選択的アゴニスト等、用途別セグメントは、等に区分しました。選択的アゴニストの世界市場概観、企業動向、企業別選択的アゴニストシェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。
・選択的アゴニストの市場概観
・選択的アゴニストの企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等）
・選択的アゴニストの企業別販売動向、市場シェア、市場集中度、競争動向
・選択的アゴニストの世界市場規模
・選択的アゴニストの北米市場分析（アメリカ、カナダ、メキシコ等）
・選択的アゴニストのアメリカ市場規模推移
・選択的アゴニストのカナダ市場規模推移
・選択的アゴニストのメキシコ市場規模推移
・選択的アゴニストのヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）
・選択的アゴニストのドイツ市場規模推移
・選択的アゴニストのイギリス市場規模推移
・選択的アゴニストのロシア市場規模推移
・選択的アゴニストのアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等）
・選択的アゴニストの日本市場規模推移
・選択的アゴニストの中国市場規模推移
・選択的アゴニストの韓国市場規模推移
・選択的アゴニストのインド市場規模推移
・選択的アゴニストの東南アジア市場規模推移
・選択的アゴニストの南米市場分析（ブラジル、アルゼンチン等）
・選択的アゴニストの中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等）
・選択的アゴニストの種類別分析/販売量、売上、市場シェア（α1選択的アゴニスト、α2選択的アゴニスト、β1選択的アゴニスト、β2選択的アゴニスト）
・選択的アゴニストの用途別分析/市場規模（）
・選択的アゴニストの市場予測2019年-2024年（地域別予測、種類別予測、用途別予測）
・選択的アゴニストの販売チャネル・代理店・貿易業者・ディーラー分析

Scope of the Report:
The global Selective Agonists market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Selective Agonists.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Selective Agonists market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Selective Agonists market by product type and applications/end industries.

Market Segment by Companies, this report covers
Merck
Bausch Health Companies
Pfizer
Sterling Winthrop
Sanofi
Paragon BioTeck
West-Ward Pharmaceuticals
Biosyent Pharma
Novartis
Omega Laboratories
Medical Purchasing Solutions
Avadel Legacy Pharmaceuticals
Amneal Biosciences
Cipla USA
Par Pharmaceutical
Glaxosmithkline
Teva
Bayer
Impax Generics
Mylan Pharmaceuticals
Physicians Total Care
Cadila Pharnmaceuticals
Alembic Pharmaceuticals
Allergan
Mylan

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
α1 Selective Agonists
α2 Selective Agonists
β1 Selective Agonists
β2 Selective Agonists

Market Segment by Applications, can be divided into
Paroxysmal Supraventricular Tachycardia
Eye Drops
Anaphylaxis
Cardiac Arrest
Anaphylaxis
Cardiac Arrest
Chronic Heart Failure
Myocardial Infarction
Postoperative Hypotension

レポート目次

Table of Contents

1 Selective Agonists Market Overview
1.1 Product Overview and Scope of Selective Agonists
1.2 Classification of Selective Agonists by Types
1.2.1 Global Selective Agonists Revenue Comparison by Types (2019-2024)
1.2.2 Global Selective Agonists Revenue Market Share by Types in 2018
1.2.3 α1 Selective Agonists
1.2.4 α2 Selective Agonists
1.2.5 β1 Selective Agonists
1.2.6 β2 Selective Agonists
1.3 Global Selective Agonists Market by Application
1.3.1 Global Selective Agonists Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Paroxysmal Supraventricular Tachycardia
1.3.3 Eye Drops
1.3.4 Anaphylaxis
1.3.5 Cardiac Arrest
1.3.6 Anaphylaxis
1.3.7 Cardiac Arrest
1.3.8 Chronic Heart Failure
1.3.9 Myocardial Infarction
1.3.10 Postoperative Hypotension
1.4 Global Selective Agonists Market by Regions
1.4.1 Global Selective Agonists Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Selective Agonists Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Selective Agonists Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Selective Agonists Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Selective Agonists Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Selective Agonists Status and Prospect (2014-2024)
1.5 Global Market Size of Selective Agonists (2014-2024)
2 Manufacturers Profiles
2.1 Merck
2.1.1 Business Overview
2.1.2 Selective Agonists Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Merck Selective Agonists Revenue, Gross Margin and Market Share (2017-2018)
2.2 Bausch Health Companies
2.2.1 Business Overview
2.2.2 Selective Agonists Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Bausch Health Companies Selective Agonists Revenue, Gross Margin and Market Share (2017-2018)
2.3 Pfizer
2.3.1 Business Overview
2.3.2 Selective Agonists Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Pfizer Selective Agonists Revenue, Gross Margin and Market Share (2017-2018)
2.4 Sterling Winthrop
2.4.1 Business Overview
2.4.2 Selective Agonists Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Sterling Winthrop Selective Agonists Revenue, Gross Margin and Market Share (2017-2018)
2.5 Sanofi
2.5.1 Business Overview
2.5.2 Selective Agonists Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Sanofi Selective Agonists Revenue, Gross Margin and Market Share (2017-2018)
2.6 Paragon BioTeck
2.6.1 Business Overview
2.6.2 Selective Agonists Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Paragon BioTeck Selective Agonists Revenue, Gross Margin and Market Share (2017-2018)
2.7 West-Ward Pharmaceuticals
2.7.1 Business Overview
2.7.2 Selective Agonists Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 West-Ward Pharmaceuticals Selective Agonists Revenue, Gross Margin and Market Share (2017-2018)
2.8 Biosyent Pharma
2.8.1 Business Overview
2.8.2 Selective Agonists Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Biosyent Pharma Selective Agonists Revenue, Gross Margin and Market Share (2017-2018)
2.9 Novartis
2.9.1 Business Overview
2.9.2 Selective Agonists Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Novartis Selective Agonists Revenue, Gross Margin and Market Share (2017-2018)
2.10 Omega Laboratories
2.10.1 Business Overview
2.10.2 Selective Agonists Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Omega Laboratories Selective Agonists Revenue, Gross Margin and Market Share (2017-2018)
2.11 Medical Purchasing Solutions
2.11.1 Business Overview
2.11.2 Selective Agonists Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Medical Purchasing Solutions Selective Agonists Revenue, Gross Margin and Market Share (2017-2018)
2.12 Avadel Legacy Pharmaceuticals
2.12.1 Business Overview
2.12.2 Selective Agonists Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Avadel Legacy Pharmaceuticals Selective Agonists Revenue, Gross Margin and Market Share (2017-2018)
2.13 Amneal Biosciences
2.13.1 Business Overview
2.13.2 Selective Agonists Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Amneal Biosciences Selective Agonists Revenue, Gross Margin and Market Share (2017-2018)
2.14 Cipla USA
2.14.1 Business Overview
2.14.2 Selective Agonists Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Cipla USA Selective Agonists Revenue, Gross Margin and Market Share (2017-2018)
2.15 Par Pharmaceutical
2.15.1 Business Overview
2.15.2 Selective Agonists Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Par Pharmaceutical Selective Agonists Revenue, Gross Margin and Market Share (2017-2018)
2.16 Glaxosmithkline
2.16.1 Business Overview
2.16.2 Selective Agonists Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Glaxosmithkline Selective Agonists Revenue, Gross Margin and Market Share (2017-2018)
2.17 Teva
2.17.1 Business Overview
2.17.2 Selective Agonists Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 Teva Selective Agonists Revenue, Gross Margin and Market Share (2017-2018)
2.18 Bayer
2.18.1 Business Overview
2.18.2 Selective Agonists Type and Applications
2.18.2.1 Product A
2.18.2.2 Product B
2.18.3 Bayer Selective Agonists Revenue, Gross Margin and Market Share (2017-2018)
2.19 Impax Generics
2.19.1 Business Overview
2.19.2 Selective Agonists Type and Applications
2.19.2.1 Product A
2.19.2.2 Product B
2.19.3 Impax Generics Selective Agonists Revenue, Gross Margin and Market Share (2017-2018)
2.20 Mylan Pharmaceuticals
2.20.1 Business Overview
2.20.2 Selective Agonists Type and Applications
2.20.2.1 Product A
2.20.2.2 Product B
2.20.3 Mylan Pharmaceuticals Selective Agonists Revenue, Gross Margin and Market Share (2017-2018)
2.21 Physicians Total Care
2.21.1 Business Overview
2.2.2 Selective Agonists Type and Applications
2.21.2.1 Product A
2.21.2.2 Product B
2.21.3 Physicians Total Care Selective Agonists Revenue, Gross Margin and Market Share (2017-2018)
2.22 Cadila Pharnmaceuticals
2.22.1 Business Overview
2.22.2 Selective Agonists Type and Applications
2.22.2.1 Product A
2.22.2.2 Product B
2.22.3 Cadila Pharnmaceuticals Selective Agonists Revenue, Gross Margin and Market Share (2017-2018)
2.23 Alembic Pharmaceuticals
2.23.1 Business Overview
2.23.2 Selective Agonists Type and Applications
2.23.2.1 Product A
2.23.2.2 Product B
2.23.3 Alembic Pharmaceuticals Selective Agonists Revenue, Gross Margin and Market Share (2017-2018)
2.24 Allergan
2.24.1 Business Overview
2.24.2 Selective Agonists Type and Applications
2.24.2.1 Product A
2.24.2.2 Product B
2.24.3 Allergan Selective Agonists Revenue, Gross Margin and Market Share (2017-2018)
2.25 Mylan
2.25.1 Business Overview
2.25.2 Selective Agonists Type and Applications
2.25.2.1 Product A
2.25.2.2 Product B
2.25.3 Mylan Selective Agonists Revenue, Gross Margin and Market Share (2017-2018)
3 Global Selective Agonists Market Competition, by Players
3.1 Global Selective Agonists Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Selective Agonists Players Market Share
3.2.2 Top 10 Selective Agonists Players Market Share
3.3 Market Competition Trend
4 Global Selective Agonists Market Size by Regions
4.1 Global Selective Agonists Revenue and Market Share by Regions
4.2 North America Selective Agonists Revenue and Growth Rate (2014-2019)
4.3 Europe Selective Agonists Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Selective Agonists Revenue and Growth Rate (2014-2019)
4.5 South America Selective Agonists Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Selective Agonists Revenue and Growth Rate (2014-2019)
5 North America Selective Agonists Revenue by Countries
5.1 North America Selective Agonists Revenue by Countries (2014-2019)
5.2 USA Selective Agonists Revenue and Growth Rate (2014-2019)
5.3 Canada Selective Agonists Revenue and Growth Rate (2014-2019)
5.4 Mexico Selective Agonists Revenue and Growth Rate (2014-2019)
6 Europe Selective Agonists Revenue by Countries
6.1 Europe Selective Agonists Revenue by Countries (2014-2019)
6.2 Germany Selective Agonists Revenue and Growth Rate (2014-2019)
6.3 UK Selective Agonists Revenue and Growth Rate (2014-2019)
6.4 France Selective Agonists Revenue and Growth Rate (2014-2019)
6.5 Russia Selective Agonists Revenue and Growth Rate (2014-2019)
6.6 Italy Selective Agonists Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Selective Agonists Revenue by Countries
7.1 Asia-Pacific Selective Agonists Revenue by Countries (2014-2019)
7.2 China Selective Agonists Revenue and Growth Rate (2014-2019)
7.3 Japan Selective Agonists Revenue and Growth Rate (2014-2019)
7.4 Korea Selective Agonists Revenue and Growth Rate (2014-2019)
7.5 India Selective Agonists Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Selective Agonists Revenue and Growth Rate (2014-2019)
8 South America Selective Agonists Revenue by Countries
8.1 South America Selective Agonists Revenue by Countries (2014-2019)
8.2 Brazil Selective Agonists Revenue and Growth Rate (2014-2019)
8.3 Argentina Selective Agonists Revenue and Growth Rate (2014-2019)
8.4 Colombia Selective Agonists Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Selective Agonists by Countries
9.1 Middle East and Africa Selective Agonists Revenue by Countries (2014-2019)
9.2 Saudi Arabia Selective Agonists Revenue and Growth Rate (2014-2019)
9.3 UAE Selective Agonists Revenue and Growth Rate (2014-2019)
9.4 Egypt Selective Agonists Revenue and Growth Rate (2014-2019)
9.5 Nigeria Selective Agonists Revenue and Growth Rate (2014-2019)
9.6 South Africa Selective Agonists Revenue and Growth Rate (2014-2019)
10 Global Selective Agonists Market Segment by Type
10.1 Global Selective Agonists Revenue and Market Share by Type (2014-2019)
10.2 Global Selective Agonists Market Forecast by Type (2019-2024)
10.3 α1 Selective Agonists Revenue Growth Rate (2014-2024)
10.4 α2 Selective Agonists Revenue Growth Rate (2014-2024)
10.5 β1 Selective Agonists Revenue Growth Rate (2014-2024)
10.6 β2 Selective Agonists Revenue Growth Rate (2014-2024)
11 Global Selective Agonists Market Segment by Application
11.1 Global Selective Agonists Revenue Market Share by Application (2014-2019)
11.2 Selective Agonists Market Forecast by Application (2019-2024)
11.3 Paroxysmal Supraventricular Tachycardia Revenue Growth (2014-2019)
11.4 Eye Drops Revenue Growth (2014-2019)
11.5 Anaphylaxis Revenue Growth (2014-2019)
11.6 Cardiac Arrest Revenue Growth (2014-2019)
11.7 Anaphylaxis Revenue Growth (2014-2019)
11.8 Cardiac Arrest Revenue Growth (2014-2019)
11.9 Chronic Heart Failure Revenue Growth (2014-2019)
11.10 Myocardial Infarction Revenue Growth (2014-2019)
11.11 Postoperative Hypotension Revenue Growth (2014-2019)
12 Global Selective Agonists Market Size Forecast (2019-2024)
12.1 Global Selective Agonists Market Size Forecast (2019-2024)
12.2 Global Selective Agonists Market Forecast by Regions (2019-2024)
12.3 North America Selective Agonists Revenue Market Forecast (2019-2024)
12.4 Europe Selective Agonists Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Selective Agonists Revenue Market Forecast (2019-2024)
12.6 South America Selective Agonists Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Selective Agonists Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source

List of Tables and Figures

Figure Selective Agonists Picture
Table Product Specifications of Selective Agonists
Table Global Selective Agonists and Revenue (Million USD) Market Split by Product Type
Figure Global Selective Agonists Revenue Market Share by Types in 2018
Figure α1 Selective Agonists Picture
Figure α2 Selective Agonists Picture
Figure β1 Selective Agonists Picture
Figure β2 Selective Agonists Picture
Table Global Selective Agonists Revenue (Million USD) by Application (2014-2024)
Figure Selective Agonists Revenue Market Share by Applications in 2018
Figure Paroxysmal Supraventricular Tachycardia Picture
Figure Eye Drops Picture
Figure Anaphylaxis Picture
Figure Cardiac Arrest Picture
Figure Anaphylaxis Picture
Figure Cardiac Arrest Picture
Figure Chronic Heart Failure Picture
Figure Myocardial Infarction Picture
Figure Postoperative Hypotension Picture
Table Global Market Selective Agonists Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Selective Agonists Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Selective Agonists Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Selective Agonists Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Selective Agonists Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Selective Agonists Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Selective Agonists Revenue (Million USD) and Growth Rate (2014-2024)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Selective Agonists Type and Applications
Table Merck Selective Agonists Revenue, Gross Margin and Market Share (2017-2018)
Table Bausch Health Companies Basic Information, Manufacturing Base and Competitors
Table Bausch Health Companies Selective Agonists Type and Applications
Table Bausch Health Companies Selective Agonists Revenue, Gross Margin and Market Share (2017-2018)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Selective Agonists Type and Applications
Table Pfizer Selective Agonists Revenue, Gross Margin and Market Share (2017-2018)
Table Sterling Winthrop Basic Information, Manufacturing Base and Competitors
Table Sterling Winthrop Selective Agonists Type and Applications
Table Sterling Winthrop Selective Agonists Revenue, Gross Margin and Market Share (2017-2018)
Table Sanofi Basic Information, Manufacturing Base and Competitors
Table Sanofi Selective Agonists Type and Applications
Table Sanofi Selective Agonists Revenue, Gross Margin and Market Share (2017-2018)
Table Paragon BioTeck Basic Information, Manufacturing Base and Competitors
Table Paragon BioTeck Selective Agonists Type and Applications
Table Paragon BioTeck Selective Agonists Revenue, Gross Margin and Market Share (2017-2018)
Table West-Ward Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table West-Ward Pharmaceuticals Selective Agonists Type and Applications
Table West-Ward Pharmaceuticals Selective Agonists Revenue, Gross Margin and Market Share (2017-2018)
Table Biosyent Pharma Basic Information, Manufacturing Base and Competitors
Table Biosyent Pharma Selective Agonists Type and Applications
Table Biosyent Pharma Selective Agonists Revenue, Gross Margin and Market Share (2017-2018)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Selective Agonists Type and Applications
Table Novartis Selective Agonists Revenue, Gross Margin and Market Share (2017-2018)
Table Omega Laboratories Basic Information, Manufacturing Base and Competitors
Table Omega Laboratories Selective Agonists Type and Applications
Table Omega Laboratories Selective Agonists Revenue, Gross Margin and Market Share (2017-2018)
Table Medical Purchasing Solutions Basic Information, Manufacturing Base and Competitors
Table Medical Purchasing Solutions Selective Agonists Type and Applications
Table Medical Purchasing Solutions Selective Agonists Revenue, Gross Margin and Market Share (2017-2018)
Table Avadel Legacy Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Avadel Legacy Pharmaceuticals Selective Agonists Type and Applications
Table Avadel Legacy Pharmaceuticals Selective Agonists Revenue, Gross Margin and Market Share (2017-2018)
Table Amneal Biosciences Basic Information, Manufacturing Base and Competitors
Table Amneal Biosciences Selective Agonists Type and Applications
Table Amneal Biosciences Selective Agonists Revenue, Gross Margin and Market Share (2017-2018)
Table Cipla USA Basic Information, Manufacturing Base and Competitors
Table Cipla USA Selective Agonists Type and Applications
Table Cipla USA Selective Agonists Revenue, Gross Margin and Market Share (2017-2018)
Table Par Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Par Pharmaceutical Selective Agonists Type and Applications
Table Par Pharmaceutical Selective Agonists Revenue, Gross Margin and Market Share (2017-2018)
Table Glaxosmithkline Basic Information, Manufacturing Base and Competitors
Table Glaxosmithkline Selective Agonists Type and Applications
Table Glaxosmithkline Selective Agonists Revenue, Gross Margin and Market Share (2017-2018)
Table Teva Basic Information, Manufacturing Base and Competitors
Table Teva Selective Agonists Type and Applications
Table Teva Selective Agonists Revenue, Gross Margin and Market Share (2017-2018)
Table Bayer Basic Information, Manufacturing Base and Competitors
Table Bayer Selective Agonists Type and Applications
Table Bayer Selective Agonists Revenue, Gross Margin and Market Share (2017-2018)
Table Impax Generics Basic Information, Manufacturing Base and Competitors
Table Impax Generics Selective Agonists Type and Applications
Table Impax Generics Selective Agonists Revenue, Gross Margin and Market Share (2017-2018)
Table Mylan Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Mylan Pharmaceuticals Selective Agonists Type and Applications
Table Mylan Pharmaceuticals Selective Agonists Revenue, Gross Margin and Market Share (2017-2018)
Table Physicians Total Care Basic Information, Manufacturing Base and Competitors
Table Physicians Total Care Selective Agonists Type and Applications
Table Physicians Total Care Selective Agonists Revenue, Gross Margin and Market Share (2017-2018)
Table Cadila Pharnmaceuticals Basic Information, Manufacturing Base and Competitors
Table Cadila Pharnmaceuticals Selective Agonists Type and Applications
Table Cadila Pharnmaceuticals Selective Agonists Revenue, Gross Margin and Market Share (2017-2018)
Table Alembic Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Alembic Pharmaceuticals Selective Agonists Type and Applications
Table Alembic Pharmaceuticals Selective Agonists Revenue, Gross Margin and Market Share (2017-2018)
Table Allergan Basic Information, Manufacturing Base and Competitors
Table Allergan Selective Agonists Type and Applications
Table Allergan Selective Agonists Revenue, Gross Margin and Market Share (2017-2018)
Table Mylan Basic Information, Manufacturing Base and Competitors
Table Mylan Selective Agonists Type and Applications
Table Mylan Selective Agonists Revenue, Gross Margin and Market Share (2017-2018)
Table Global Selective Agonists Revenue (Million USD) by Players (2014-2019)
Table Global Selective Agonists Revenue Share by Players (2014-2019)
Figure Global Selective Agonists Revenue Share by Players in 2017
Figure Global Selective Agonists Revenue Share by Players in 2018
Figure Global Top 5 Players Selective Agonists Revenue Market Share in 2018
Figure Global Top 10 Players Selective Agonists Revenue Market Share in 2018
Figure Global Selective Agonists Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Selective Agonists Revenue (Million USD) by Regions (2014-2019)
Table Global Selective Agonists Revenue Market Share by Regions (2014-2019)
Figure Global Selective Agonists Revenue Market Share by Regions (2014-2019)
Figure Global Selective Agonists Revenue Market Share by Regions in 2018
Figure North America Selective Agonists Revenue and Growth Rate (2014-2019)
Figure Europe Selective Agonists Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Selective Agonists Revenue and Growth Rate (2014-2019)
Figure South America Selective Agonists Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Selective Agonists Revenue and Growth Rate (2014-2019)
Table North America Selective Agonists Revenue by Countries (2014-2019)
Table North America Selective Agonists Revenue Market Share by Countries (2014-2019)
Figure North America Selective Agonists Revenue Market Share by Countries (2014-2019)
Figure North America Selective Agonists Revenue Market Share by Countries in 2018
Figure USA Selective Agonists Revenue and Growth Rate (2014-2019)
Figure Canada Selective Agonists Revenue and Growth Rate (2014-2019)
Figure Mexico Selective Agonists Revenue and Growth Rate (2014-2019)
Table Europe Selective Agonists Revenue (Million USD) by Countries (2014-2019)
Figure Europe Selective Agonists Revenue Market Share by Countries (2014-2019)
Figure Europe Selective Agonists Revenue Market Share by Countries in 2018
Figure Germany Selective Agonists Revenue and Growth Rate (2014-2019)
Figure UK Selective Agonists Revenue and Growth Rate (2014-2019)
Figure France Selective Agonists Revenue and Growth Rate (2014-2019)
Figure Russia Selective Agonists Revenue and Growth Rate (2014-2019)
Figure Italy Selective Agonists Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Selective Agonists Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Selective Agonists Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Selective Agonists Revenue Market Share by Countries in 2018
Figure China Selective Agonists Revenue and Growth Rate (2014-2019)
Figure Japan Selective Agonists Revenue and Growth Rate (2014-2019)
Figure Korea Selective Agonists Revenue and Growth Rate (2014-2019)
Figure India Selective Agonists Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Selective Agonists Revenue and Growth Rate (2014-2019)
Table South America Selective Agonists Revenue by Countries (2014-2019)
Table South America Selective Agonists Revenue Market Share by Countries (2014-2019)
Figure South America Selective Agonists Revenue Market Share by Countries (2014-2019)
Figure South America Selective Agonists Revenue Market Share by Countries in 2018
Figure Brazil Selective Agonists Revenue and Growth Rate (2014-2019)
Figure Argentina Selective Agonists Revenue and Growth Rate (2014-2019)
Figure Colombia Selective Agonists Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Selective Agonists Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Selective Agonists Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Selective Agonists Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Selective Agonists Revenue Market Share by Countries in 2018
Figure Saudi Arabia Selective Agonists Revenue and Growth Rate (2014-2019)
Figure UAE Selective Agonists Revenue and Growth Rate (2014-2019)
Figure Egypt Selective Agonists Revenue and Growth Rate (2014-2019)
Figure Nigeria Selective Agonists Revenue and Growth Rate (2014-2019)
Figure South Africa Selective Agonists Revenue and Growth Rate (2014-2019)
Table Global Selective Agonists Revenue (Million USD) by Type (2014-2019)
Table Global Selective Agonists Revenue Share by Type (2014-2019)
Figure Global Selective Agonists Revenue Share by Type (2014-2019)
Figure Global Selective Agonists Revenue Share by Type in 2018
Table Global Selective Agonists Revenue Forecast by Type (2019-2024)
Figure Global Selective Agonists Market Share Forecast by Type (2019-2024)
Figure Global α1 Selective Agonists Revenue Growth Rate (2014-2019)
Figure Global α2 Selective Agonists Revenue Growth Rate (2014-2019)
Figure Global β1 Selective Agonists Revenue Growth Rate (2014-2019)
Figure Global β2 Selective Agonists Revenue Growth Rate (2014-2019)
Table Global Selective Agonists Revenue by Application (2014-2019)
Table Global Selective Agonists Revenue Share by Application (2014-2019)
Figure Global Selective Agonists Revenue Share by Application (2014-2019)
Figure Global Selective Agonists Revenue Share by Application in 2018
Table Global Selective Agonists Revenue Forecast by Application (2019-2024)
Figure Global Selective Agonists Market Share Forecast by Application (2019-2024)
Figure Global Paroxysmal Supraventricular Tachycardia Revenue Growth Rate (2014-2019)
Figure Global Eye Drops Revenue Growth Rate (2014-2019)
Figure Global Anaphylaxis Revenue Growth Rate (2014-2019)
Figure Global Cardiac Arrest Revenue Growth Rate (2014-2019)
Figure Global Anaphylaxis Revenue Growth Rate (2014-2019)
Figure Global Cardiac Arrest Revenue Growth Rate (2014-2019)
Figure Global Chronic Heart Failure Revenue Growth Rate (2014-2019)
Figure Global Myocardial Infarction Revenue Growth Rate (2014-2019)
Figure Global Postoperative Hypotension Revenue Growth Rate (2014-2019)
Figure Global Selective Agonists Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Selective Agonists Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Selective Agonists Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Selective Agonists Revenue Market Forecast (2019-2024)
Figure Europe Selective Agonists Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Selective Agonists Revenue Market Forecast (2019-2024)
Figure South America Selective Agonists Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Selective Agonists Revenue Market Forecast (2019-2024)

Global β1 Adrenoceptor Agonists Market 2019 by Company, Regions, Type and Application, Forecast to 2024
B-GIR08C6508 2019年7月 123Pages
本調査レポートは、β1アドレナリン受容体作動薬の世界市場について調べ、まとめました。種類別セグメントは、ドブタミン、デノパミン、ザモテロール、その他等、用途別セグメントは、等に区分しました。β1アドレナリン受容体作動薬の世界市場概観、企業動向、企業別β1アドレナリン受容体作動薬シェア、市場規模推移、...

β2アドレナリン受容体作動薬の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024）

Global β2 Adrenoceptor Agonists Market 2019 by Company, Regions, Type and Application, Forecast to 2024
B-GIR08C6509 2019年7月 136Pages
本調査レポートは、β2アドレナリン受容体作動薬の世界市場について調べ、まとめました。種類別セグメントは、アルブテロール、テルブタリン、サルメテロール、ホルモテロール、ピルブテロール等、用途別セグメントは、等に区分しました。β2アドレナリン受容体作動薬の世界市場概観、企業動向、企業別β2アドレナリン受...

非選択的アゴニストの世界市場予測 2024年：企業別、地域別、種類・用途別（～2024）

Global Nonselective Agonists Market 2019 by Company, Regions, Type and Application, Forecast to 2024
B-GIR08C4044 2019年7月 138Pages
本調査レポートは、非選択的アゴニストの世界市場について調べ、まとめました。種類別セグメントは、アドレナリン、ノルアドレナリン、イソプレナリン、ドーパミン等、用途別セグメントは、等に区分しました。非選択的アゴニストの世界市場概観、企業動向、企業別非選択的アゴニストシェア、市場規模推移、市場規模予測（2...

βアドレナリン受容体作動薬の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024）

Global β Adrenoceptor Agonists Market 2019 by Company, Regions, Type and Application, Forecast to 2024
B-GIR08C6507 2019年7月 139Pages
本調査レポートは、βアドレナリン受容体作動薬の世界市場について調べ、まとめました。種類別セグメントは、イソプレナリン、ドブタミン、サルブタモール、テルブタリン、サルメテロール、ホルモテロール、ピルブテロール等、用途別セグメントは、等に区分しました。βアドレナリン受容体作動薬の世界市場概観、企業動向、...

選択的Cox-2阻害剤の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024）

Global Selective Cox-2 Inhibitors Market 2019 by Company, Regions, Type and Application, Forecast to 2024
B-GIR08C5102 2019年7月 138Pages
本調査レポートは、選択的Cox-2阻害剤の世界市場について調べ、まとめました。種類別セグメントは、メロキシカム、セレコキシブ、エトリコキシブ、イムレコキシブ、エトドラク、パレコキシブ、その他等、用途別セグメントは、等に区分しました。選択的Cox-2阻害剤の世界市場概観、企業動向、企業別選択的Cox-...

選択的レーザー焼結（SLS）プリンターの世界市場予測 2019年：メーカー別、地域別、種類・用途別（～2024）

Global Selective Laser Sintering (SLS) Printers Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
B-GIR08C5103 2019年8月 135Pages
本調査レポートは、選択的レーザー焼結（SLS）プリンターの世界市場について調べ、まとめました。種類別セグメントは、固体レーザー、ガスレーザー等、用途別セグメントは、自動車、航空宇宙、消費財、機械設備、アート及びファッション、医療機器、その他等に区分しました。選択的レーザー焼結（SLS）プリンターの世...

選択的コンプライアンスアセンブリロボットアーム（SCARA）ロボットの世界市場予測 2019年：メーカー別、地域別、種類・用途別（～2024）

Global Selective Compliance Assembly Robot Arm (SCARA) Robots Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
B-GIR08C5101 2019年8月 122Pages
本調査レポートは、選択的コンプライアンスアセンブリロボットアーム（SCARA）ロボットの世界市場について調べ、まとめました。種類別セグメントは、シングルアームスカラ、デュアルアームスカラ等、用途別セグメントは、産業用、医療用、その他等に区分しました。選択的コンプライアンスアセンブリロボットアーム（S...

硫黄選択検出器の世界市場予測 2019年：メーカー別、地域別、種類・用途別（～2024）

Global Sulfur Selective Detector Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
B-GIR08C5578 2019年8月 122Pages
本調査レポートは、硫黄選択検出器の世界市場について調べ、まとめました。種類別セグメントは、硫黄化学発光検出器（SCD）、フレーム光度検出器（FPD）、質量分析検出器（MSD）、原子発光検出（AED）等、用途別セグメントは、炭化水素基質、天然ガス、軽油、残留燃料、その他等に区分しました。硫黄選択検出器...

便秘治療薬の世界市場予測 2019年：メーカー別、地域別、種類・用途別（～2024）

Global Constipation Treatment Drug Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
B-GIR08C1451 2019年8月 136Pages
本調査レポートは、便秘治療薬の世界市場について調べ、まとめました。種類別セグメントは、下剤、塩化物チャネル活性化剤、5-HT 4受容体作動薬、GC-C作動薬、末梢作用ミューオピオイド受容体拮抗薬等、用途別セグメントは、小売薬局、病院薬局、オンライン薬局等に区分しました。便秘治療薬の世界市場概観、企業...

カルシウムチャネル遮断薬の世界市場予測 2019年：メーカー別、地域別、種類・用途別（～2024）

Global Calcium Channel Blockers Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
B-GIR08C0981 2019年8月 121Pages
本調査レポートは、カルシウムチャネル遮断薬の世界市場について調べ、まとめました。種類別セグメントは、選択的遮断薬：フェニルアルキルアミン（PPA）、ジヒドロピリジン（DHP）、ベンゾチアゼピン（BTZ）、非選択的遮断薬等、用途別セグメントは、高血圧、冠状動脈疾患、不整脈、心筋症等に区分しました。カル...

β1アドレナリン受容体作動薬の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） Scope of the Report: The global β1 Adrenoceptor Agonists market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, …
β2アドレナリン受容体作動薬の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） Scope of the Report: The global β2 Adrenoceptor Agonists market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, …
βアドレナリン受容体作動薬の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） Scope of the Report: The global β Adrenoceptor Agonists market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, a…
非選択的アゴニストの世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） Scope of the Report: The global Nonselective Agonists market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, als…
イオン選択透過性樹脂市場：世界及び中国市場分析・予測（～2024年） Ion Selective Permeation Resin Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Ion Selective Permeation Resin industry with a focus on the Chinese market. The report provides key statistics on the market status of the Ion Sele…